---
title: The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy
  in Myeloma-Associated Kidney Failure
date: '2024-05-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38790994/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240525190013&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Kidney involvement with resulting kidney failure leads to increased mortality
  in patients with multiple myeloma (MM). Cast nephropathy (CN), in particular, if
  left untreated, quickly leads to kidney failure requiring dialysis and has a very
  poor prognosis for the affected patient. The gold standard for diagnosing kidney
  involvement is a kidney biopsy. However, due to bleeding risk, this cannot be done
  in every patient. We recently reported that a quotient of urine light chain (LCurine)
  ...
disable_comments: true
---
Kidney involvement with resulting kidney failure leads to increased mortality in patients with multiple myeloma (MM). Cast nephropathy (CN), in particular, if left untreated, quickly leads to kidney failure requiring dialysis and has a very poor prognosis for the affected patient. The gold standard for diagnosing kidney involvement is a kidney biopsy. However, due to bleeding risk, this cannot be done in every patient. We recently reported that a quotient of urine light chain (LCurine) ...